Expertise in
11
conditions

Charlotte S. Ulrik

Copenhagen, DK 
Expertise in
11
conditions
Copenhagen, DK 

Overview

Charlotte Ulrik practices practicing medicine in Copenhagen, Denmark.

Ms. Ulrik is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Asthma, Chronic Obstructive Pulmonary Disease (COPD), Asthma in Children, and Cerebral Hypoxia.

She is actively involved in clinical research, co-authoring 290 peer reviewed articles and participating in 5 clinical trials.

Gender

Female

Locations

Copenhagen, Denmark
Other Locations
Hvidovre, Denmark
Bispebjerg, Denmark
Hellerup, 2900, Denmark
Herlev, Denmark
Arhus, Denmark
Alle, 2650, Denmark
Virum, 4011, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
Enrollment Status: Completed
Publish Date: August 21, 2026
Intervention Type: Drug, Biological
Study Drug: Mepolizumab
Study Phase: Phase 3
Use of Omalizumab Will Increase the Pregnancy Rate, Proof of Concept Study, Where Women With Asthma and Infertility Will be Treated Three Times With Weight and IgE Balanced Dosis at the First Day of Their Period Bleeding
Use of Omalizumab Will Increase the Pregnancy Rate, Proof of Concept Study, Where Women With Asthma and Infertility Will be Treated Three Times With Weight and IgE Balanced Dosis at the First Day of Their Period Bleeding
Enrollment Status: Completed
Publish Date: April 08, 2025
Intervention Type: Drug
Study Drug: Omalizumab
Study Phase: Phase 2
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
Rethink Pulmonary Rehabilitation (REPORT Study)
Rethink Pulmonary Rehabilitation (REPORT Study)
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Other
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study
Enrollment Status: Completed
Publish Date: March 27, 2023
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

290 Total Publications

Risk and outcome of interstitial lung disease in inflammatory bowel disease: evidence from a Danish nationwide population-based cohort study.
Risk and outcome of interstitial lung disease in inflammatory bowel disease: evidence from a Danish nationwide population-based cohort study.
Journal: Journal of Crohn's & colitis
Published: June 30, 2026

Frequently Asked Questions about Charlotte S. Ulrik

Is Charlotte S. Ulrik a top-rated expert for Asthma?

MediFind is an objective health platform that identifies experts based on real-world data. Charlotte S. Ulrik is classified as an Elite expert for Asthma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Charlotte S. Ulrik participate in research or clinical trials?

Yes. Charlotte S. Ulrik has published 290 articles and abstracts on conditions like Asthma. You can view a list of Charlotte S. Ulrik's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ulrik's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile